Login/Sign Up
Letrozit 2.5 Tab 5'S
₹118.8*
MRP ₹132
10% off
₹112.2*
MRP ₹132
15% CB
₹19.8 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Letrozit 2.5 Tab belongs to the group of anti-cancer medicines called aromatase inhibitors used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.
Letrozit 2.5 Tab contains 'Letrozole' that works by blocking the aromatase enzyme, which is involved in the production of the estrogen hormone. The cancer cells require estrogen for their growth. Hence, by blocking the aromatase enzyme, Letrozit 2.5 Tab prevents the growth of cancer cells. Thereby Letrozit 2.5 Tab helps in preventing or stopping the growth of spreading the tumours (cancer cells) to other body parts.
You are advised to take Letrozit 2.5 Tab for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, Letrozit 2.5 Tab may cause certain common side-effects such as hypercholesterolemia (increased cholesterol levels), tiredness, weakness, increased sweating, feeling unwell, pain in joints, and hot flushes (feeling of warmth). Do not be reluctant to talk with your doctor if you experience any of these side-effects persistently.
Avoid taking Letrozit 2.5 Tab if you are pregnant or breastfeeding. Letrozit 2.5 Tab may cause drowsiness and dizziness, so drive only if you are alert. Letrozit 2.5 Tab should not be given to children as safety has not been established. Avoid consuming alcohol along with Letrozit 2.5 Tab as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.
Letrozit 2.5 Tab belongs to the group of anti-cancer medicines called aromatase inhibitors. Letrozit 2.5 Tab is used to treat breast cancer in women who have gone through menopause (cessation of periods). Letrozit 2.5 Tab works by blocking the aromatase enzyme, which is involved in the production of estrogens. The cancer cells require estrogen for their growth, so by blocking the enzyme Letrozit 2.5 Tab prevents the growth of cancer cells. Thereby, Letrozit 2.5 Tab helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.
Do not take Letrozit 2.5 Tab if you are allergic to any of its contents, if you have not yet gone through menopause (still get your periods). Talk to your doctor before taking Letrozit 2.5 Tab if you have osteoporosis (thinning of bones), bone fractures, severe liver or kidney disease. Letrozit 2.5 Tab may cause inflammation in tendons or tendon injury; contact your doctor if you observe any sign of tendon pain or swelling while taking Letrozit 2.5 Tab. Avoid taking Letrozit 2.5 Tab if you are pregnant or breastfeeding. Letrozit 2.5 Tab may cause drowsiness and dizziness, so drive only if you are alert. Letrozit 2.5 Tab should not be given to children as safety has not been established. Avoid consuming alcohol along with Letrozit 2.5 Tab as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications before taking Letrozit 2.5 Tab to rule out any side-effects.
Drug-Drug Interactions: Letrozit 2.5 Tab may interact with antidepressants (citalopram, escitalopram) and anticancer (tamoxifen).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have high cholesterol, osteoporosis (thinning of bone), or liver disease.
Eat a healthy diet and exercise regularly to maintain proper weight.
Avoid smoking and alcohol consumption.
Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, herbs and spices in your diet.
Avoid fast food, fried food, processed meats, refined carbs and added sugar.
Get optimal sleep; rest well.
Your doctor may advise you to regularly measure bone density before, during and after the treatment as Letrozit 2.5 Tab may cause bone thinning due to reduction of estrogens in the body.
Letrozit 2.5 Tab should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Letrozit 2.5 Tab.
Breast cancer: It is a type of cancer that develops in breast cells which are stimulated by the female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. The tumour cells invade other healthy breast cells and can travel to lymph nodes which are a primary pathway for the cancer cells to move to other parts of the body. Symptoms of breast cancer include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Letrozit 2.5 Tab to avoid unpleasant side effects. Alcohol intake, along with Letrozit 2.5 Tab, may cause increased drowsiness.
Pregnancy
Unsafe
Letrozit 2.5 Tab is pregnancy category D medicine so, should not be taken during pregnancy.
Breast Feeding
Unsafe
Letrozit 2.5 Tab should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby.
Driving
Caution
Letrozit 2.5 Tab may cause dizziness and drowsiness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Safe if prescribed
It is safe to take Letrozit 2.5 Tab if prescribed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Safe if prescribed
It is safe to take Letrozit 2.5 Tab if prescribed. Please consult your doctor if you have kidney impairment or any concerns regarding this. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min.
Children
Unsafe
Letrozit 2.5 Tab should not be used by children, as the efficacy and safety have not been established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes